Evidence map›Paper›PMID 34265240›Full record

ArticleCell host & microbe2021

Beyond neutralization for BNT162b2 mRNA vaccination.

Payal Damani-Yokota, Stephen T Yeung, Kamal M Khanna

Abstract readComment
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Study of humoral and cellular immunity in vaccinated with mRNA-1273.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2022
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Payal Damani-YokotaDepartment of Microbiology, New York University Langone Health, New York, NY, USA.
Stephen T YeungDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA.
Kamal M KhannaDepartment of Microbiology, New York University Langone Health, New York, NY, USA; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA. Electronic address: kamal.khanna@nyulangone.org.

Funding

Novel lung resident interstitial macrophage subset with distinct localization and polarizationR01AI143861 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KHANNA, KAMAL MOHAN · 2019 to 2023
$3.3M
Lung resident macrophage subsets in regulating tissue immunity - Resubmission - 1F32HL154598 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAMANI-YOKOTA, PAYAL · 2021 to 2022
$85k
NHLBI NIH HHS F32 HL154598NIAID NIH HHS R01 AI143861
6 · The paper itself

Abstract

Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2.

Indexed as

COVID-19SARS-CoV-2BNT162 VaccineCOVID-19 VaccinesHumansRNA, MessengerVaccinationBNT162 VaccineCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID34265240
PMCPMC8279510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.